The National Institutes of Health will spend about $1.1 billion this year on research to prevent and treat opioid addiction, NIH Director Francis Collins, M.D., announced today. The Helping to End Addiction Long-term Initiative will study patients after acute onset of musculoskeletal pain and after surgery to identify biomarkers that might predict those more likely to transition from acute to chronic pain; genetic and social factors that put patients at risk for opioid misuse and addiction; and best practices for pain management using nondrug and integrated therapies for specific pain conditions. It also will pursue public-private partnerships to develop new non-addictive pain medicines; build a clinical trials network to allow multiple compounds to be tested simultaneously for effectiveness; research additional treatment options for addiction and neonatal opioid withdrawal syndrome; and test prevention and treatment options in health care and criminal justice settings in states with the highest opioid misuse and overdose rates.

Related News Articles

Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…
Headline
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
Headline
AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic…
Headline
The Food and Drug Administration last week required certain labeling updates for opioid pain medicines in an effort to reduce unnecessary prescribing and…